Over the next five years, Pitt will receive a nearly $62.3 million in funding from the National Institutes of Health.

Pitt’s Clinical and Translational Science Institute will receive the funding to quicken the translation of scientific research into treatment. The initiatives CTSI will be working on during the five-year funding span will include biomedical modeling, integrating populations more sensitive to exposure to hazardous substances and collaborative multidisciplinary research.

“This award is emblematic of the significant contribution that University of Pittsburgh researchers and physicians are continuing to make to advance our understanding of biomedical science and improve clinical care,” Arthur Levine, the dean of Pitt’s School of Medicine, said in a release.

The funding is provided through NIH’s National Center for Advancing Translational Sciences.

CTSI was one of the first 12 recipients of the NIH’s Clinical and Translational Science Awards in 2006. Pitt has received more than $221 million in CTSA awards since then. So far, Pitt’s CTSI-supported programs have been awarded $108 million in research funding for the next five years.